Cliantha Research Limited

Form 483 issued April 17, 2026 · Ahmedabad, India

Inspection
Apr 13 – Apr 17, 2026
Observations
6
Pages
5
FEI number
3017682080

In short: On April 17, 2026, FDA issued a Form 483 with 6 observations to Cliantha Research Limited in Ahmedabad, Gujarat (FEI 3017682080) after an inspection that ran Apr 13 – Apr 17, 2026. The investigators were Anna M. Brannen, Kara A. Scheibner, Koffi A. Amegadje and Miguel A. Martinez. Most observations concern clinical (BIMO).

At a glance

Observations span 1 system, led by clinical (bimo).

Clinical (BIMO)1
Other5

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 02
    21 CFR 320.38

    The firm did not maintain all source…

  3. 03

    The fimi was unable to account for missing sample volume in samples…

  4. 04

    The film reported inaccurate data in the bioanalytical report…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Cliantha Research Limited?

FDA listed 6 observations on this Form 483, mostly about clinical (BIMO). The opening words of each observation are shown on this page.

Who inspected Cliantha Research Limited?

Anna M. Brannen, Kara A. Scheibner, Koffi A. Amegadje and Miguel A. Martinez are named on this Form 483, for the inspection of Apr 13 – Apr 17, 2026. Each investigator has a profile showing what they cite most.

When was Cliantha Research Limited inspected by FDA?

The inspection ran Apr 13 – Apr 17, 2026, and the Form 483 is dated April 17, 2026.

How do I get the full Form 483 for Cliantha Research Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free